{
    "clinical_study": {
        "@rank": "83866", 
        "arm_group": [
            {
                "arm_group_label": "Closone", 
                "arm_group_type": "Experimental", 
                "description": "75mg/100mg per day, 4weeks, PO"
            }, 
            {
                "arm_group_label": "Plavix with Astrix", 
                "arm_group_type": "Active Comparator", 
                "description": "Plavix 75mg with Astrix 100mg, 4weeks, PO"
            }
        ], 
        "brief_summary": {
            "textblock": "The Aim of this study is to prove non-inferiority of Closone to the Combination treatment of\n      Plavix with Astrix."
        }, 
        "brief_title": "Comparison of the Efficacy and Safety of Closone and Clopidogrel With Aspirin", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Coronary Artery Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects under condition after Post-Percutaneous Coronary Artery Intervention over\n             twelve months\n\n          -  20~85 years old\n\n          -  Willing to adhere to protocol requirements and sign a informed consent form\n\n        Exclusion Criteria:\n\n          -  Subject who did not undergo or failed Stent Implantation\n\n          -  Subjects who took an anti-coagulant, anti-thrombotic regularly before the study, or\n             plan to have continuous treatment during the study\n\n          -  Subjects with a history of hypersensitivity to Clopidogrel, Aspirin\n\n          -  Subjects with uncontrolled severe hypertension\n\n          -  Subjects with high risk of hemorrhage like blood coagulation disorders\n\n             :gastrointestinal bleeding, gross hematuria, intraocular bleeding, hemorrhagic\n             stroke, intracranial hemorrhage\n\n          -  Subjects with intractable arrhythmia, intracranial hemorrhage\n\n          -  Subjects with Severe cardiomyopathy (New York Heart Association(NYHA) Class \u2163)\n\n          -  Subjects with Severe hepatopathy(AST and ALT > 10 times the upper limit of normal)\n\n          -  Subjects who are pregnant, breastfeeding and not using medically acceptable birth\n             control\n\n          -  Subjects considered as unsuitable based on medical judgement by investigators"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "92", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01763749", 
            "org_study_id": "CLO_1201"
        }, 
        "intervention": [
            {
                "arm_group_label": "Closone", 
                "description": "Closone 75mg/100mg, 4weeks, PO", 
                "intervention_name": "Closone", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Plavix with Astrix", 
                "description": "Plavix 75mg with Astrix 100mg, 4weeks, PO", 
                "intervention_name": "Plavix with Astrix", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Clopidogrel"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 9, 2013", 
        "location": {
            "contact": {
                "email": "sungmin@catholic.ac.kr", 
                "last_name": "Sung Min Lim, MD", 
                "phone": "82-2-2258-1139"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "state": "Seochogu", 
                    "zip": "137-701"
                }, 
                "name": "Cardiovascular Center and Cardiology Division, Seoul St. Mary's Hospital"
            }, 
            "investigator": {
                "last_name": "Ki-bae Seung, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparison of the Efficacy and Safety of Closone and Clopidogrel With Aspirin in Korean Patients With Coronary Artery Disease (a Single-center, Randomized, Open-label Clinical Trial)", 
        "overall_contact": {
            "email": "kbseung@catholic.ac.kr", 
            "last_name": "Ki-Bae Seung, MD, PhD", 
            "phone": "82-2-2258-1139"
        }, 
        "overall_contact_backup": {
            "email": "kiyuk@catholic.ac.kr", 
            "last_name": "Kiyuk Chang, MD, PhD", 
            "phone": "82-2-2258-1139"
        }, 
        "overall_official": {
            "affiliation": "Cardiovascular center and Cardiology Division, Seoul St. Mary's Hospital", 
            "last_name": "Ki-Bae Seung, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change from baseline in P2Y12% inhibition at week 4", 
            "safety_issue": "No", 
            "time_frame": "Baseline, week 4"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01763749"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul St. Mary's Hospital", 
            "investigator_full_name": "Kiyuk Chang", 
            "investigator_title": "Associate professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "PRU : VerifyNow P2Y12 reaction unit", 
                "measure": "Change from baseline in PRU at week 4", 
                "safety_issue": "No", 
                "time_frame": "Baseline, week 4"
            }, 
            {
                "description": "ARU : VerifyNow Aspirin Reaction Unit", 
                "measure": "Change from baseline in ARU at week 4", 
                "safety_issue": "No", 
                "time_frame": "Baseline, week 4"
            }
        ], 
        "source": "Seoul St. Mary's Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul St. Mary's Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}